Pharmaceutical Technology Europe E-Alert

Pharmaceutical Technology E-Alert: Having trouble viewing this e-mail? Click here.

BLOG

EVENT CALENDAR

COLUMNS

WHITE PAPERS

THE MAGAZINE

15 January 2013

PRINT SUBSCRIBE

IN THIS ISSUE
• News
• Regulatory Roundup
• Industry Briefs
• Webcasts
• Events
• About Us

Abbott Spins off AbbVie as Independent BioPharm Company
AbbVie, a research-focused, specialty biopharmaceutical company recently spun off from Abbott, was officially launched earlier this month. More...

Big Pharma's Shrinking Firepower for M&A Deals
Over the last two years, the gap between analysts' estimates of big pharma sales and the global drug market forecast by IMS Health has widened significantly. More...

Falsified Medicines Directive Takes Shape in Europe
The EU’s Falsified Medicines Directive comes into effect this month to tackle the growing problem of counterfeit medicines, but some of the finer details still have to be worked out. More...

Partnership Aims to Advance Malaria Vaccine R&D
The PATH Malaria Vaccine Initiative and Inovio Pharmaceuticals have announced a follow-on collaboration to advance the development of malaria vaccines and new vaccine delivery technologies. More...

Eli Lilly Announces 2013 Financial Guidance
Eli Lilly expects overall revenue growth in 2013 and claims that the company is on track to meet or exceed its minimum financial performance targets. More...

Shire Acquires Lotus Tissue Repair
Shire has signed an agreement to acquire Lotus Tissue Repair, Inc., a biotechnology company developing the first and only protein replacement therapy for a genetic orphan disease that causes fragile skin and recurring blisters. More...

The Effect of FDA's Process Validation Guidance on Industry
How has the FDA process validation guidance, Guidance for Industry: Process Validation: General Principles and Practices, changed validation in pharmaceutical manufacturing? PharmTech is looking for your answers as part of an upcoming special feature. More...

Product Profiles

Agilent

Together: It's how we work. It's how we help Pharma Succeed.
Look to Agilent for real world solutions that help pharmaceutical companies discover more rapidly and more efficiently.
The Agilent RapidFire High-throughput System and 6550 iFunnel Q-TOF mass spec helped one lab reduce a week of work to 4.5 hours, transforming their productivity. Discover more, and request your free ADME Solutions Guide at our new pharma web page

www.agilent.com/chem/togetherADME

Shimadzu

The world's fastest LCMS/MS tandem mass spectrometer
Shimadzu's LCMS-8040 combines newly improved ion optics and collision cell technology with proprietary ultrafast technologies. This significantly expands the application range and ensures high-sensitivity, high-throughput analysis at lower levels of detection.

Event Profiles

PHARM Connect Congress 2013

27th – 28th February 2013, Budapest

The Annual PHARM Connect Congress for Enlarged Europe is one of the largest pharmaceutical and biotechnology manufacturing events in Central and Eastern Europe and the CIS market in 2013. The event is bringing together around 500 senior decision-makers from Europe's leading pharmaceutical and biotechnology companies, giving them the opportunity to share their knowledge and discuss their key priorities.

Pharmapack Europe

13-14 February 2013, Grande Halle de la Villette, Paris, France
How Innovations in Pharma Packaging and Drug Delivery Technologies Enhance Patient Safety and Compliance.